|
|
LETTER TO THE EDITOR |
|
Year : 2009 | Volume
: 57
| Issue : 4 | Page : 324-325 |
|
Entrapment of intravitreal triamcinolone behind the crystalline lens
Amjad Salman, Pragya Parmar, Vanila G Coimbatore, Rajmohan Meenakshisunderam, Nelson Jesudasan A Christdas
Institute of Ophthalmology, Joseph Eye Hospital, Tiruchirapalli - 620 001, India
Date of Web Publication | 30-Jun-2009 |
Correspondence Address: Amjad Salman Institute of Ophthalmology, Joseph Eye Hospital, Tiruchirapalli - 620 001 India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0301-4738.53066
How to cite this article: Salman A, Parmar P, Coimbatore VG, Meenakshisunderam R, Christdas NJ. Entrapment of intravitreal triamcinolone behind the crystalline lens. Indian J Ophthalmol 2009;57:324-5 |
Dear Editor,
Intravitreal triamcinolone acetonide (IVTA) has been increasingly applied as a treatment of diabetic macular edema. Complications include glaucoma, cataract and endophthalmitis. [1],[2],[3] Complications such as endophthalmitis can produce a sudden, profound decrease in vision. We report a patient in whom triamcinolone became entrapped behind the crystalline lens following IVTA injection leading to a sudden but temporary visual loss.
A 49-year-old diabetic patient presented with proliferative diabetic retinopathy and macular edema in both eyes. Visual acuity was 20/60 in both eyes and the lens was clear. Fundus fluorescein angiography confirmed the presence of new vessels with diffuse leaks in the macula. The patient was treated with pan-retinal photocoagulation and grid laser. One month later, his visual acuity remained 20/60 in the right eye but dropped to 20/200 in the left eye. Optical coherence tomography (OCT) showed a diffuse thickening in the macula with a foveal thickness of 740µ.
Under peribulbar anesthesia, 0.1 cc (4mg) of triamcinolone acetonide was injected in the inferotemporal quadrant 4mm from the limbus using a 26G needle in the left eye. At the moment of injection, the patient made a sudden jerky movement. After injection, the surgeon noted that the drug appeared immobile just behind the lens. As a part of routine protocol, the patient was instructed not to lie down for 6 hours.
On the first post-operative day, the patient's visual acuity in the left eye dropped to hand movements. Slit lamp examination showed the drug between the posterior capsule of the lens and the anterior hyaloid face [Figure 1]. There was no view of the fundus but an ultrasound B scan exam revealed a clear vitreous. One week later, the drug deposit started to clear [Figure 2] and it cleared completely by two weeks leaving a clear lens [Figure 3]. Visual acuity improved to 20/40 and the foveal thickness decreased to 260µ. The lens remained clear with a follow up of 7 months.
Sudden decrease of visual acuity after IVTA injection is usually related to endophthalmitis. Anterior segment problems after IVTA are rare and include vitreous prolapse into anterior chamber with or without intraocular lens (IOL) decentration and opaque coating over the IOL. [4],[5]
In our patient, we believe that the head movement at the time of injection caused the drug to be delivered into the Berger's space between the posterior lens capsule and the anterior hyaloid face where it remained trapped due to the normal adhesions. Although surgical removal via the pars plana was an option, we preferred a conservative approach to avoid damage to the lens. In any event, the drug cleared over the next 4 weeks with the lens remaining clear. This complication could have been probably avoided through better communication with the patient regarding the need to avoid movements during the procedure. This case highlights the importance of proper technique of intravitreal injections.
In conclusion, intravitreal triamcinolone acetonide may become entrapped behind the crystalline lens if the needle is not properly positioned. Conservative management allows the drug to clear without trauma to the crystalline lens.
References | | |
1. | Gillies MC, Simpson JM, Billson FA, Luo W, Penfold P, Chua W, et al. Safety of an intravitreal injection of triamcinolone: Results from a randomized clinical trial. Arch Ophthalmol 2004;122:336-40. [ PUBMED] |
2. | Thompson JT. Cataract formation and other complications of intravitreal triamcinolone acetonide for macular edema. Am J Ophthalmol 2006;141:629-37. [ PUBMED] [ FULLTEXT] |
3. | Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, et al. Acute endophthalmitis after intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-6. [ PUBMED] [ FULLTEXT] |
4. | Degenring RF, Sauder G. Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinilone acetonide. Graefes Arch Clin Exp Ophthalmol 2006;244:1043-4. [ PUBMED] [ FULLTEXT] |
5. | Chen SD, Chen FK, Patel C. Opaque coating of the intraocular lens and regression of iris neovascularization following injection of triamcinolone acetonide into the anterior chamber. Clin Exp Ophthalmol 2006;34:803-5. |
[Figure 1], [Figure 2], [Figure 3]
This article has been cited by | 1 |
Incidence and Risk Factors for Berger’s Space Development after Uneventful Cataract Surgery: Evidence from Swept-Source Optical Coherence Tomography |
|
| Zhengwei Zhang, Jinhan Yao, Shuimiao Chang, Piotr Kanclerz, Ramin Khoramnia, Minghui Deng, Xiaogang Wang | | Journal of Clinical Medicine. 2022; 11(13): 3580 | | [Pubmed] | [DOI] | | 2 |
Lenticular deposits of intravitreal triamcinolone acetonide |
|
| Richa Agarwal, Alka Tripathi, Mohit Agarwal | | Indian Journal of Ophthalmology - Case Reports. 2022; 2(4): 1003 | | [Pubmed] | [DOI] | | 3 |
Retrolental Hemorrhage in Berger's Space After Intravitreal Bevacizumab Injection for Retinopathy of Prematurity |
|
| Pooja Rajesh Shah, Anusha Sachan, Parijat Chandra | | Journal of Pediatric Ophthalmology & Strabismus. 2020; 57(6) | | [Pubmed] | [DOI] | | 4 |
Distribution of fluorescein sodium and triamcinolone acetonide in the simulated liquefied and vitrectomized Vitreous Model with simulated eye movements |
|
| Sandra Stein, Malte Bogdahn, Christoph Rosenbaum, Werner Weitschies, Anne Seidlitz | | European Journal of Pharmaceutical Sciences. 2017; 109: 233 | | [Pubmed] | [DOI] | | 5 |
Neodymium: Yttrium-aluminum-garnet laser anterior hyaloidotomy to treat trapped triamcinolone acetonide behind the crystalline lens after intravitreal injection |
|
| Ascaso, F.J., De Gopegui, E.R., Cascante, J.M. | | Middle East African Journal of Ophthalmology. 2012; 19(1): 163-165 | | [Pubmed] | |
|
|
|
|